Citations (35)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Takeharu Kanazawa, Kiyoshi Misawa, Kazuya Shinmura, Yuki Misawa, Gen Kusaka, Mikiko Maruta, Toru Sasaki, Yusuke Watanabe & Thomas E. Carey. (2019) Promoter methylation of galanin receptors as epigenetic biomarkers for head and neck squamous cell carcinomas. Expert Review of Molecular Diagnostics 19:2, pages 137-148.
Read now
Read now
Nicholas P. Campbell, Thomas A. Hensing, Mihir K. Bhayani, Arif Y. Shaikh & Bruce E. Brockstein. (2016) Targeting pathways mediating resistance to anti-EGFR therapy in squamous cell carcinoma of the head and neck. Expert Review of Anticancer Therapy 16:8, pages 847-858.
Read now
Read now
Articles from other publishers (33)
Anna M. Cyran, Florian Kleinegger, Norbert Nass, Michael Naumann, Johannes Haybaeck & Christoph Arens. (2023) Inhibition of EIF2α Dephosphorylation Decreases Cell Viability and Synergizes with Standard-of-Care Chemotherapeutics in Head and Neck Squamous Cell Carcinoma. Cancers 15:22, pages 5350.
Crossref
Crossref
Silvia Mara Baez Rodriguez, Amira Kamel, Gheorghe Vasile Ciubotaru, Gelu Onose, Ani-Simona Sevastre, Veronica Sfredel, Suzana Danoiu, Anica Dricu & Ligia Gabriela Tataranu. (2023) An Overview of EGFR Mechanisms and Their Implications in Targeted Therapies for Glioblastoma. International Journal of Molecular Sciences 24:13, pages 11110.
Crossref
Crossref
Xinxin Yu, Yanling Du, Shumin Liang, Na Zhang, Sun Jing, Linlin Sui, Ying Kong, Ming Dong & Hui Kong. (2023) OPN up-regulated proliferation and invasion of head and neck squamous cell carcinoma through the p38MAPK signaling pathway. Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology 136:1, pages 70-79.
Crossref
Crossref
Harshita Nivrutti Khedkar, Lung-Ching Chen, Yu-Cheng Kuo, Alexander T. H. Wu & Hsu-Shan Huang. (2023) Multi-Omics Identification of Genetic Alterations in Head and Neck Squamous Cell Carcinoma and Therapeutic Efficacy of HNC018 as a Novel Multi-Target Agent for c-MET/STAT3/AKT Signaling Axis. International Journal of Molecular Sciences 24:12, pages 10247.
Crossref
Crossref
Kevin Brown Chandler, Carlos Humberto Pavan, Hannah G. Cotto Aparicio & Robert Sackstein. (2023) Enrichment and nLC-MS/MS Analysis of Head and Neck Cancer Mucinome Glycoproteins. Journal of Proteome Research 22:4, pages 1231-1244.
Crossref
Crossref
James J. Kang, Albert Ko, Sang Hoon Kil, Jon Mallen-St. Clair, Daniel Sanghoon Shin, Marilene B. Wang & Eri S. Srivatsan. (2023) EGFR pathway targeting drugs in head and neck cancer in the era of immunotherapy. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 1878:1, pages 188827.
Crossref
Crossref
Yang Xiang, Lujie Si, Ying Zheng & Huiming Wang. (2022) Shikonin enhances chemosensitivity of oral cancer through β‐catenin pathway. Oral Diseases.
Crossref
Crossref
Mourad Assidi, Abdelbaset Buhmeida & Bruce Budowle. (2022) Medicine and health of 21st Century: Not just a high biotech-driven solution. npj Genomic Medicine 7:1.
Crossref
Crossref
Silvia Pisani, Giulia Bertino, Adriele Prina-Mello, Laura Deborah Locati, Simone Mauramati, Ida Genta, Rossella Dorati, Bice Conti & Marco Benazzo. (2022) Electroporation in Head-and-Neck Cancer: An Innovative Approach with Immunotherapy and Nanotechnology Combination. Cancers 14:21, pages 5363.
Crossref
Crossref
Abul Azad & Anthony Kong. (2022) The Therapeutic Potential of Imidazole or Quinone-Based Compounds as Radiosensitisers in Combination with Radiotherapy for the Treatment of Head and Neck Squamous Cell Carcinoma. Cancers 14:19, pages 4694.
Crossref
Crossref
Su-Bin Park, Woo Jung, Hyung Kim, Hwa-Young Yu, Yong Kim & Junghyun Kim. (2022) Esculetin has therapeutic potential via the proapoptotic signaling pathway in A253 human submandibular salivary gland tumor cells. Experimental and Therapeutic Medicine 24:2.
Crossref
Crossref
Brittany Montesino, Agata Steenackers, Juan M Lozano, Geoffrey D Young, Nan Hu, Robert Sackstein & Kevin Brown Chandler. (2022) Identification of α1,2-fucosylated signaling and adhesion molecules in head and neck squamous cell carcinoma. Glycobiology 32:5, pages 441-455.
Crossref
Crossref
Zejia Yang, Jipei Liao, Rena G. Lapidus, Xiaoxuan Fan, Ranee Mehra, Kevin J. Cullen & Hancai Dan. (2022) Targeting Wee1 kinase to suppress proliferation and survival of cisplatin-resistant head and neck squamous cell carcinoma. Cancer Chemotherapy and Pharmacology 89:4, pages 469-478.
Crossref
Crossref
Nurettin Sezer, İbrahim Arı, Yusuf Biçer & Muammer Koç. (2021) Superparamagnetic nanoarchitectures: Multimodal functionalities and applications. Journal of Magnetism and Magnetic Materials 538, pages 168300.
Crossref
Crossref
Wei-Ting Hsueh, Shang-Hung Chen, Chia-Hung Chien, Shao-Wen Chou, Pei-I Chi, Jui-Mei Chu & Kwang-Yu Chang. (2021) SOD2 Enhancement by Long-Term Inhibition of the PI3K Pathway Confers Multi-Drug Resistance and Enhanced Tumor-Initiating Features in Head and Neck Cancer. International Journal of Molecular Sciences 22:20, pages 11260.
Crossref
Crossref
Katja Tuomainen, Aini Hyytiäinen, Ahmed Al-Samadi, Philipp Ianevski, Aleksandr Ianevski, Swapnil Potdar, Laura Turunen, Jani Saarela, Sergey Kuznetsov, Wafa Wahbi, Maija Risteli, Antti Mäkitie, Outi Monni & Tuula Salo. (2021) High-throughput compound screening identifies navitoclax combined with irradiation as a candidate therapy for HPV-negative head and neck squamous cell carcinoma. Scientific Reports 11:1.
Crossref
Crossref
Lejla Mahmutović, Esma Bilajac & Altijana Hromić-Jahjefendić. (2021) Meet the Insidious Players: Review of Viral Infections in Head and Neck Cancer Etiology with an Update on Clinical Trials. Microorganisms 9:5, pages 1001.
Crossref
Crossref
Geet Madhukar & Naidu Subbarao. (2021) Current and Future Therapeutic Targets: A Review on Treating Head and Neck Squamous Cell Carcinoma. Current Cancer Drug Targets 21:5, pages 386-400.
Crossref
Crossref
Ujjwala M. Warawdekar, Vaishali Jain, Himani Patel, Adyasha Nanda & Vishal Kamble. (2021) Modifying gap junction communication in cancer therapy. Current Research in Translational Medicine 69:1, pages 103268.
Crossref
Crossref
Chaoying Wu, Lingxia Tong, Chaoqun Wu, Dong Chen, Jianguo Chen, Qianyun Li, Fang Jia & Zirui Huang. (2020) Two miRNA prognostic signatures of head and neck squamous cell carcinoma: A bioinformatic analysis based on the TCGA dataset. Cancer Medicine 9:8, pages 2631-2642.
Crossref
Crossref
Mohammed E. Grawish, Mohamed I. Mourad, Doaa AM Esmaeil, Rehab A Ahmed, Islam Mohamed Ateia, Eman Hany & Mazen Tharwat Abou Elkhier. (2020) Emerging therapeutic modality enhancing the efficiency of chemotherapeutic agents against head and neck squamous cell carcinoma cell lines. Cancer Treatment and Research Communications 25, pages 100242.
Crossref
Crossref
Katja Tuomainen, Ahmed Al-Samadi, Swapnil Potdar, Laura Turunen, Minna Turunen, Piia-Riitta Karhemo, Paula Bergman, Maija Risteli, Pirjo Åström, Riia Tiikkaja, Reidar Grenman, Krister Wennerberg, Outi Monni & Tuula Salo. (2019) Human Tumor–Derived Matrix Improves the Predictability of Head and Neck Cancer Drug Testing. Cancers 12:1, pages 92.
Crossref
Crossref
Rintu Thomas & Zhang Weihua. (2019) Rethink of EGFR in Cancer With Its Kinase Independent Function on Board. Frontiers in Oncology 9.
Crossref
Crossref
Dorothy M K Keefe & Emma H Bateman. (2019) Potential Successes and Challenges of Targeted Cancer Therapies. JNCI Monographs 2019:53.
Crossref
Crossref
Zhipeng Li, Jipei Liao, Zejia Yang, Eun Yong Choi, Rena G. Lapidus, Xuefeng Liu, Kevin J. Cullen & Hancai Dan. (2018) Co-targeting EGFR and IKKβ/NF-κB signalling pathways in head and neck squamous cell carcinoma: a potential novel therapy for head and neck squamous cell cancer. British Journal of Cancer 120:3, pages 306-316.
Crossref
Crossref
Hailong Ma, Shufang Jin, Wenyi Yang, Ge Zhou, Mei Zhao, Sijie Fang, Zhiyuan Zhang & Jingzhou Hu. (2018) Interferon-alpha enhances the antitumour activity of EGFR-targeted therapies by upregulating RIG-I in head and neck squamous cell carcinoma. British Journal of Cancer 118:4, pages 509-521.
Crossref
Crossref
Mary Jue Xu, Daniel E. Johnson & Jennifer R. Grandis. (2017) EGFR-targeted therapies in the post-genomic era. Cancer and Metastasis Reviews 36:3, pages 463-473.
Crossref
Crossref
Hua Shen, Xiaobo Yu, Fengming Yang, Zhihua Zhang, Jianxin Shen, Jin Sun, Swati Choksi, Siriporn Jitkaew & Yongqian Shu. (2016) Reprogramming of Normal Fibroblasts into Cancer-Associated Fibroblasts by miRNAs-Mediated CCL2/VEGFA Signaling. PLOS Genetics 12:8, pages e1006244.
Crossref
Crossref
Bárbara Filipa Adem, Nuno Ricardo Alves Bastos, Francisca Dias, Ana Luísa Teixeira & Rui Medeiros. (2016) miRNAs: mediators of ErbB family targeted therapy resistance. Pharmacogenomics 17:10, pages 1175-1187.
Crossref
Crossref
Shuyang Sun & Zhiyuan Zhang. (2016) Patient-derived xenograft platform of OSCC: a renewable human bio-bank for preclinical cancer research and a new co-clinical model for treatment optimization. Frontiers of Medicine 10:1, pages 104-110.
Crossref
Crossref
Loredana Vesci, Ferdinando Maria Milazzo, Anna Maria Anastasi, Fiorella Petronzelli, Caterina Chiapparino, Valeria Carollo, Giuseppe Roscilli, Emanuele Marra, Laura Luberto, Luigi Aurisicchio, Maria Lucrezia Pacello, Luigi Giusto Spagnoli & Rita De Santis. (2015) Intra-tumor AvidinOX allows efficacy of low dose systemic biotinylated Cetuximab in a model of head and neck cancer. Oncotarget 7:1, pages 914-928.
Crossref
Crossref
Astrid De Meulenaere, Tijl Vermassen, Sandrine Aspeslagh, Karen Zwaenepoel, Philippe Deron, Fréderic Duprez, Liesbeth Ferdinande & Sylvie Rottey. (2016) CD70 Expression and Its Correlation with Clinicopathological Variables in Squamous Cell Carcinoma of the Head and Neck. Pathobiology 83:6, pages 327-333.
Crossref
Crossref
Takeharu Kanazawa, Kiyoshi Misawa, Yuki Misawa, Takayuki Uehara, Hirofumi Fukushima, Gen Kusaka, Mikiko Maruta & Thomas Carey. (2015) G-Protein-Coupled Receptors: Next Generation Therapeutic Targets in Head and Neck Cancer?. Toxins 7:8, pages 2959-2984.
Crossref
Crossref